Title: Contextualized Networks Reveal Heterogeneous Transcriptomic Regulation in Tumors at Sample-Specific Resolution
Authors: Caleb N. Ellington, Benjamin J. Lengerich, Thomas B.K. Watkins, Jiekun Yang, Manolis Kellis, Eric P. Xing
Section: 
project 23, 4441–4449. URL https://www.ncbi.nlm.nih.gov/pmc/articles/400 PMC5785562/.401 [17] Cherniack, A. D. et al. Integrated molecular characterization of uterine carcinosarcoma 31, 411–423. URL402 https://www.cell.com/cancer-cell/abstract/S1535-6108(17)30053-3. Publisher: El-403 sevier.404 [18] Kim, J. et al. Integrated genomic characterization of oesophageal carcinoma 541, 169–175. URL https:405 //www.nature.com/articles/nature20805. Number: 7636 Publisher: Nature Publishing Group.406 [19] Ceccarelli, M. et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in407 diffuse glioma 164, 550–563. URL https://www.sciencedirect.com/science/article/pii/408 S009286741501692X.409 [20] The molecular taxonomy of primary prostate cancer 163, 1011–1025. URL https://www.ncbi.nlm.410 nih.gov/pmc/articles/PMC4695400/.411 [21] Davis, C. F. et al. The somatic genomic landscape of chromophobe renal cell carcinoma 26, 319–330. URL412 https://www.sciencedirect.com/science/article/pii/S1535610814003043.413 [22] Levine, D. A. Integrated genomic characterization of endometrial carcinoma 497, 67–73. URL https://414 www.nature.com/articles/nature12113. Number: 7447 Publisher: Nature Publishing Group.415 [23] Cohen, A., Holmen, S. & Colman, H. IDH1 and IDH2 mutations in gliomas 13, 345. URL https://www.416 ncbi.nlm.nih.gov/pmc/articles/PMC4109985/.417 [24] Ben-Hamo, R. et al. Predicting and affecting response to cancer therapy based on pathway-level biomarkers 11,418 3296.419 [25] Badia-i Mompel, P. et al. Gene regulatory network inference in the era of single-cell multi-omics 1–16.420 URL https://www.nature.com/articles/s41576-023-00618-5. Publisher: Nature Publishing421 Group.422 [26] Stone, M. et al. Identifying strengths and weaknesses of methods for computational network inference from423 single cell RNA-seq data. URL https://www.biorxiv.org/content/10.1101/2021.06.01.424 446671v1. Publication Title: bioRxiv.425 [27] Pratapa, A., Jalihal, A. P., Law, J. N., Bharadwaj, A. & Murali, T. M. Benchmarking algorithms for gene426 regulatory network inference from single-cell transcriptomic data 17, 147–154.427 [28] Thompson, D., Regev, A. & Roy, S. Comparative analysis of gene regulatory networks:428 from network reconstruction to evolution 31, 399–428. URL http://dx.doi.org/10.1146/429 annurev-cellbio-100913-012908.430 [29] Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering 14, 1083–1086. URL https:431 //www.nature.com/articles/nmeth.4463. Number: 11 Publisher: Nature Publishing Group.432 [30] Kuijjer, M. L., Tung, M. G., Yuan, G., Quackenbush, J. & Glass, K. Estimating sample-specific regulatory433 networks 14, 226–240. URL http://dx.doi.org/10.1016/j.isci.2019.03.021.434 [31] Lazareva, O. et al. DysRegNet: Patient-specific and confounder-aware dysregulated network infer-435 ence. URL https://www.biorxiv.org/content/10.1101/2022.04.29.490015v1. Pages:436 2022.04.29.490015 Section: New Results.437 17 [32] Ursu, O. et al. Massively parallel phenotyping of coding variants in cancer with perturb-seq 40, 896–905.438 URL https://www.nature.com/articles/s41587-021-01160-7. Number: 6 Publisher: Nature439 Publishing Group.440 [33] Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from441 33 types of cancer 173, 291–304.e6. URL https://www.ncbi.nlm.nih.gov/pmc/articles/442 PMC5957518/.443 [34] Ageenko, I. I., Doherty, K. A. & Cleave, A. P. V. Personalized lifetime financial planning tool. URL https:444 //patents.google.com/patent/US20100161467/en.445 [35] Buettner, F. et al. Computational analysis of cell-to-cell heterogeneity in single-cell RNA-sequencing data reveals446 hidden subpopulations of cells 33, 155–160. URL https://www.nature.com/articles/nbt.3102.447